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Purpose: To evaluate the efficacy and safety of the pars plana clip (PPC) in the Ahmed valve 
tube inserted via the pars plana in patients with secondary refractory glaucomas.
Methods: Prospective and interventional case series that included 10 patients with secondary 
refractory glaucoma. The pars plana vitrectomy and the implant of the modified tube were 
performed during the same surgery. Control of intraocular pressure (IOP) and the development 
of intra- and postoperative complications were evaluated during the follow-up.
Results: Follow-up time was twelve months in all the patients. Control of IOP was achieved in 
90% of patients, and 70% needed no antiglaucoma treatment. The complications that occurred 
were transient hypotony in three cases, choroidal detachment in two cases, and one case of 
intraocular hemorrhage. No case of tube extrusion or tube kink was observed.
Conclusions: Our data suggests that implantation of the Ahmed tube modified with the PPC 
via the pars plana is safe and effective in patients with secondary refractory glaucomas.
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Introduction
Different types of drainage devices for the treatment of glaucoma have been evaluated 
for decades and such devices have been classified into two types: nonvalvular (Molteno, 
Baerveldt) and valvular (Ahmed). The latter only allows the flow of aqueous humor 
when the intraocular pressure exceeds a certain value, thus avoiding possible extreme 
postoperative hypotony; their success rates are similar to those of other valvular 
devices.
All valvular devices present a common characteristic; their drainage tubes are 
  typically implanted through the corneal limbus into the anterior chamber. Efficacy in 
the control of intraocular pressure goes from 75% to 90% and complications develop 
in 30% or 40% of patients.1–5 The most typical complications are: hyphema; endothelial 
decompensation; obstruction or extrusion of the drainage tube; conjunctival erosion 
with exposure of the tube; iritis; malignant glaucoma; pupillary block; and choroidal 
detachments, which are more frequent when there are anatomical alterations of the 
anterior segment.
As an alternative to implantation of drainage tubes in the anterior chamber, some 
ophthalmologists prefer to insert the drainage tube through the pars plana and leave 
it in the vitreous cavity thus avoiding the numerous complications resulting from 
the presence of the tube in the anterior chamber.6–12 The percentage of successful 
results is normally around 90%, which is similar to that reported in studies on tube 
implants in the anterior chamber. Tube implantation in the vitreous chamber is not Clinical Ophthalmology 2010:4 412
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exempt from complications, amongst which are acute 
postoperative hypotony,9 transient choroidal detachment,9 
vitreous hemorrhage, retinal detachment,7,8 extrusion of 
the tube, or obstruction through kinking at the sclerectomy 
site.13 No study has described the typical complications of 
tube implantation in the anterior chamber, such as corneal 
  decompensation, hyphaema, exposure of the tube by 
  conjunctival erosion, iritis, or blocked pupils.
To avoid kinking and extrusion of the tube when it is 
implanted via the pars plana, two devices were developed that 
allowed the tube to be anchored to the sclera and at the same 
time to be given a suitable angle. The first was the Hoffman 
elbow which was used to modify the Baerveldet nonvalvular 
drainage device; it has been evaluated in two previous 
  studies.14,15 In the case of Ahmed’s glaucoma valve, the pars 
plana clip (PPC) was developed as a modification; as far as we 
know it has only been evaluated in one previous study.16
The aim of our study was to evaluate the efficacy and 
safety of the PPC in controlling intraocular pressure (IOP) 
when performing a vitrectomy and implant of an Ahmed’s 
valve drainage tube, via the pars plana, during the same 
surgical procedure in patients with secondary refractory 
glaucoma.
Methods
The patients included in this prospective interventionist study 
were selected by the Ophthalmology Service of the University 
General Hospital of Valencia. The patients presented with 
secondary glaucoma refractory to medical treatment or 
glaucoma surgery (trabeculectomy, cryocyclodestruction). 
All the participants were aged over 18 years and gave their 
informed consent before being included in the study.
The following data were collected and analyzed: 
  demographic characteristics of the patients (age, gender); 
type of glaucoma; together with medical treatment and 
previous surgery. The intraocular pressure was measured by 
Goldman’s tonometry. Surgery was defined as “ﾭsuccessful” 
when the IOP was 21 mmHg without the help of any 
antiglaucoma medication. Data was also collected for any 
antiglaucoma treatment necessary at each visit, the need 
of further surgery or complications developed during 
  surgery, during the follow-up period. The patients’ follow-
up examinations were performed at 1 day, 1 week, 1 month,   
3 months, 6 months, and 1 year after surgery.
The Wilcoxon nonparametrical significance test for paired 
data was used to analyze the difference between preoperative 
and postoperative IOP, taking P as 0.05 or under to consider 
the differences as statistically significant.
Surgical procedure
All the patients received pars plana vitrectomy and implant 
of the modified Ahmed valve in the same standard 3-port 
surgery. Special attention was paid to eliminating the anterior 
vitreous during surgery. Cataract surgery was also performed 
on phakic patients in the same surgical act.
All the patients received model FP7 flexible silicone 
Ahmed valves (New World Medical, Rancho Cucamonga, 
CA, USA) modified with the PPC. This valve consists of 
a 16 × 13 mm episcleral drainage plate and a tube with an 
external diameter of 0.64 mm. The PPC is a silicone device 
with an entry orifice in the upper face and an exit orifice in 
the lower face which the silicone tube passes through.
Once the vitrectomy had been performed the valve was 
purged with saline serum and sutured at 15 mm from the 
corneal limbus, with 5.0 nylon in either of the two superior 
quadrants. Then the drainage tube was inserted through the 
PPC and next through one of the sclerectomies used for the 
vitrectomy at 3.5 mm from the corneal limbus; after that, 5 or 
6 mm of the tube was introduced into the eye, making sure it 
was visible through the dilated pupil. The PPC was sutured to 
the sclera with 8.0 nylon, over which a patch of bovine peri-
cardium Tutopatch (Tutogen Medical, Bavaria, Germany) was 
also sutured with 8.0 nylon. Once the surgery was complete 
everything was covered with the conjunctiva (Figures 1−4).
Results
Ten modified Ahmed valves were implanted through the pars 
plana in ten patients with secondary refractory glaucoma during 
the year the study lasted. All the patients received twelve 
months’ follow-up and none of the patients initially included 
in the study was excluded from the results analyses.
Patient demographics
Demographic and preoperative data are shown in Table 1. The 
average age of the patients was 54.4 years. All the patients pre-
sented with chronic glaucoma refractory to medical treatment or 
surgery (Trabeculectomy, cyclocoagulation). Three patients had 
neovascular glaucoma in which the ischemic process had been 
controlled previously by means of pan photocoagulation by 
argon laser or transscleral pan cryocoagulation. Three patients 
had secondary glaucoma due to uveitis and were receiving 
chronic corticosteroid treatment (one of them had an intraocular 
fluocinolone deposit). Two patients presented with secondary 
traumatic glaucoma; and a further two patients presented with 
secondary glaucoma after penetrating keratoplasty.
Implantation via the pars plana was chosen for the two 
patients with secondary traumatic glaucoma because of Clinical Ophthalmology 2010:4 413
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repeated anterior chamber surgery, although they did not 
present with secondary angle closure. Six of the patients were 
pseudophakic, two were aphakic, and two were phakic before 
  surgery. Two of the patients, one with uveitis secondary 
glaucoma and the other with secondary traumatic glaucoma, 
had previously undergone a partial vitrectomy which was 
completed at the same time as the implant of the valves.
Intraocular pressure results
The mean preoperative IOP was 32 mmHg and the mean 
postoperative IOP at one year was 16 mmHg with significant 
statistical differences (P = 0.001) (Table 1). We were able to 
control IOP in 9 out of 10 of the patients (90%). Seven patients 
(70%) did not require antiglaucoma medication to control IOP. 
Two of the three patients who needed additional medication 
only required topical treatment (Timolol), the remaining patient 
needed three topical drugs (Dorzolamide, Brimonidine and 
Bimatoprost) resulting in one uncontrolled IOP of 24 mmHg.
Complications
The majority of the complications were transitory; notable 
among these were three cases of transitory postoperative 
hypotony (30%), two cases of choroidal detachment (20%), 
two cases of transitory ocular hypertension (20%), and one 
case of vitreous hemorrhage (10%) which was the same 
patient who suffered a total retinal detachment.
The cases of transitory hypertension were due to: the 
  presence of a vitreous strand that was obstructing the 
entry of the tube in one case; and to the development of a 
  perivalvular fibrosis in the other. In both cases we obtained an 
  instantaneous resolution by using YAG laser on the vitreous 
bridle and by needling together with 0.2% mitomycin-C.
It is important to emphasize that there were no cases of 
conjunctival erosion from exposure of the PPC, extrusion of 
the drainage tube or its obstruction due to kinking. Neither 
were complications, such as corneal decompensation or 
hyphema observed.
Figure 1 Once the vitrectomy had been performed the Ahmed’s FP7 valve (New  World 
Medical, Ranch Cucamoga, CA, USA) was purged with saline serum and sutured 15 mm 
from the corneal limbus with 5.0 nylon in either of the two superior quadrants.
Figure 2 The pars plana clip is a silicone device with an entry orifice in the upper face 
and an exit orifice in the lower face which the silicone tube passes through.
Figure 3 Five or six mm of the drainage tube was introduced into the eye through 
one of the sclerectomies used for the vitrectomy at 3.5 mm from the corneal limbus, 
making sure it was visible through the dilated pupil. The PPC was then sutured to 
the sclera with 8.0 nylon.
Figure 4 A patch of bovine pericardium Tutopatch (Tutogen Medical) was sutured 
over the pars plana clip with 8.0 nylon, and everything was then covered with the 
conjunctiva.Clinical Ophthalmology 2010:4 414
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Discussion
Over the years, therapeutic alternatives have been developed 
for patients with glaucoma refractory to conventional 
  therapies, such as, treatment with antimetabolites in 
  trabeculectomy or performing different cyclodestructive 
  procedures. These alternatives have not managed to 
  control IOP in all patients and they put the patient at risk of 
  developing potentially severe complications.
Development of drainage implants to create an alternative 
pathway for the exit of aqueous humor have been evolving 
since the 1960’s providing better success rates and a 
  diminishing frequency of complications. From the beginning, 
the drainage tubes of these valvular implants were placed in 
the anterior chamber of the eye. The presence of a tube in the 
anterior chamber generates a great number of complications, 
among which endothelial decompensation and hyphema are 
the most serious. These complications were more frequent in 
cases of complex glaucoma, such as neovascular glaucomas 
after keratoplasty, uveitis or traumatism as these usually 
develop a closing angle of 360°.
The technique of implanting the drainage tubes in the vit-
reous chamber, via the pars plana was developed and provided 
a solution to these cases. Studies in the literature using this 
technique focused on glaucomas with previous shallow 
anterior chamber, extensive angular closing, neovascular 
glaucomas, and glaucomas with associated vitreoretinal 
pathology.11,12,17 The frequency of success varied, depend-
ing on the study, from 75% to 90%. New complications 
also appeared with this technique, two of which should be 
described: the first involves the extrusion of the tube due to 
deficient fixation to the sclera; the second consists of the 
secondary obstruction of the tube by kinking caused by the 
force vectors generated at the sclerectomy site.
Two studies were recently published that evaluate 
devices in conjunction with drainage tubes that diminish 
the incidence of these complications. The first, by Lutrull 
  evaluated Hoffman’s elbow for implanting Baerveldt’s 
valves.18 Subsequently the PPC was developed which makes 
it possible to anchor an Ahmed’s valve tube to the sclera 
and give it the suitable angle for insertion through the pars 
plana into the vitreous chamber in the same act. Schlote 
was the first, and only one to our knowledge, to evaluate its 
efficiency, reporting successful results of around 90%.16 No 
cases were observed evidencing the extrusion of the tube or 
its obstruction by kinking. We consider, however, that there 
are two debatable factors in this work: the first is that at least 
three months elapsed between the time of the vitrectomy and 
the valvular implant; and the second is the use of polypro-
pylene Ahmed valves.
In the present study we modified these factors for the 
reasons detailed below. In our study, the vitrectomy was 
performed during the same surgery for the implant of an 
Ahmed’s valve, with a view to: optimizing the resources; 
lessening patient stress associated with further surgery; 
and controlling the patients’ earlier ocular hypertension. 
We believe that delay in the treatment of patients with 
  uncontrolled glaucomas can involve serious damage to the 
optical nerve. Moreover, the implant of Ahmed valves at 
the level of the pars plana should not be limited exclusively 
to non-phakic or pseudophakic patients; given that phakic 
patients can undergo cataract surgery during the same 
  surgical procedure, as was achieved in two of our patients. 
We chose silicone valves since polypropylene valves have 
proved to be a major cause of inflammation.19
In this study we implanted ten PPC-modified Ahmed 
valves via the pars plana in ten patients with secondary angle 
Table 1 Summary of results
Patient no Diagnosis Eye Age Preoperative IOP Postoperative IOP Complications
1 Neovascular R 72 40 mmHg 24 mmHg Transitory hypotony  
Vitreous hemorrhage  
Choroidal detachment
2 Neovascular L 64 35 mmHg 20 mmHg Transitory hypertension
3 Keratoplasty L 59 26 mmHg 14 mmHg Transitory hypotony  
Choroidal detachment
4 Traumatism L 44 30 mmHg 12 mmHg
5 Neovascular R 70 38 mmHg 18 mmHg
6 Uveitis R 36 24 mmHg 12 mmHg Transitory hypotony
7 Uveitis L 54 34 mmHg 13 mmHg Transitory hypertension
8 Keratoplasty R 62 32 mmHg 15 mmHg
9 Traumatism L 49 32 mmHg 14 mmHg
10 Uveitis R 34 29 mmHg 18 mmHgClinical Ophthalmology 2010:4 415
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closure glaucoma, refractory to medical treatment and/or 
conventional filtered surgery. We were able to control IOP in 
90% of patients. No additional antiglaucoma medication was 
necessary in 70% of patients to control IOP and IOP control 
only proved unsuccessful for 10% of patients in spite of the 
associated antiglaucoma medication.
We observed none of the typical complications that 
have occurred with the implant of tubes via the pars plana 
in the past resulting from of either extrusion of the tube or 
its obstruction due to kinking at the entry site to the eye. 
This is because the PPC gives the tube a firmer anchorage 
on the sclera and due to a stable entry angle. Neither were 
  conjunctival erosions with exposure of the PPC observed, 
possibly because it was covered by a pericardium patch. Three 
cases of transitory postoperative hypotony were observed, 
one of which was complicated by a choroidal detachment 
and postoperative vitreous hemorrhage, which resulted in 
a total retinal detachment. This patient presented with an 
advanced neovascular glaucoma secondary to an inadequately 
  controlled diabetic retinopathy. The patient rejected further 
surgery after being informed of the therapeutic alternatives. 
This case demonstrates that patients can develop serious 
  complications with this surgical technique and that it is 
  essential to confront each case individually. We propose 
three possible methods to prevent postoperative hypotony. 
The first is an intravitreal injection of SF6 or C3f8 gas on 
  completing surgery. The second is the partial occlusion of the 
tube with an adjustable suture that is released immediately 
after surgery. The third is the use of pediatric Ahmed valves 
that present a smaller sized plate and therefore a smaller 
filtration surface. In our study, two patients developed post-
operative hypotony owing to the presence of vitreous at the 
mouth of the tube resulting in the development of perivalvular 
fibrosis; this was solved simply and immediately with the 
use of a YAG laser on the tube and needling together with 
0.2% mitomycin-C.
We believe the implant of Ahmed’s valves through 
the pars plana in patients with secondary closure angle 
  glaucoma is more effective and avoids a considerable 
number of complications than the implant of valves in 
the anterior chamber. The combined surgery of vitrec-
tomy and valvular implant does not increase the technical 
  difficulty of the surgery excessively, nor does it involve an 
increase in the rate of complications. On the other hand, 
this preliminary study presents certain limitations, such as 
the relatively short follow-up period, and the low number 
of participants, which was due to a shortage of patients 
who complied with the selection criteria. The study design 
also has certain limitations: ie, being noncomparative and 
nonrandomized. The need of further studies is warranted in 
order to establish the long term efficacy and safety of the 
PPC. However, our data suggest that the use of the PPC for 
inserting Ahmed’s valve tube through the pars plana makes 
it possible to control the IOP of patients with refractory 
glaucoma caused by secondary angular closing in a safe 
and effective way.
In conclusion, this study shows that due to the complexity 
of some patients’ pathological conditions, it is essential 
to establish globalized surgical strategies, appropriately 
termed “ﾭfrom pole to pole”, that blur the limits of surgical 
sub-specialties in ophthalmology.
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